In March 2018, a patient who had had her hair transplants removed in Germany’s capital received a new transplant after she had a tumour removed.
The transplant, which took place at the University Hospital in Frankfurt, was a successful operation.
The transplant was conducted by Dr Rolf Schumacher and Dr Hans Gebauer, both in-house specialists at the university.
The donor hair had been removed from a patient in her 40s and the transplants had been performed on her backside, and a new scalp had been inserted in the area.
The procedure had been described as “unprecedented” in Germany, and was hailed as a major step forward for the country.
The patient, whose name has not been revealed, had suffered from a rare form of cancer called Burkitt’s lymphoma and the surgery had been done without anaesthetic.
The new transplant had been carried out at a hospital in Frankfurt but was carried out in the city’s Stadthalle.
The hospital said that in this case the patient was able to undergo the surgery without any complications.
“This is a huge step forward in the fight against this disease,” said Dr Schumachers medical director, Dr Hans Kieser, in a statement.
“With this successful transplant, we have created a whole new generation of patients who can now be fully informed about their chances of living and dying with the disease.”
Dr Gebaur said that the patient had had “significant” tumours removed from her back, but that the tumours had not spread outwards and were not harmful to her immune system.
“She has had a lot of medical challenges and she has lost the ability to do many activities and activities she would normally do, but she is still able to live her life,” he said.
“I think that her future is still very bright.”
He said that patients should be “wary” of their future in Germany because of the increased number of people with the rare and deadly disease.
“We have to take care of patients as if they were our own, not like someone else, which is why it is so important that we do everything possible to ensure patients have a good outcome in Germany,” he added.
Dr Gernot Schmitt, a specialist in the treatment of Burkitts lymphoma, said that there were still a few hurdles ahead for patients with the condition.
“There is a very high risk for cancer to develop in the new tumour, and we need to monitor them closely, especially if they have an early stage of the disease,” he told RTE.
“That means monitoring their blood, their urine and their bowel movements and if there are any abnormal movements of their intestines, we should be aware of that.”
Follow Dave Lee on Twitter: @DaveLeeABC